131 related articles for article (PubMed ID: 15828229)
1. [Polymorphisms of PPARs and metabolic disorders].
Araki E; Igata M; Motoshima H; Tsuruzoe K
Nihon Rinsho; 2005 Apr; 63(4):617-22. PubMed ID: 15828229
[TBL] [Abstract][Full Text] [Related]
2. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
Kravchenko NA; Iarmysh NV
Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
Yahia RB; Lichnovská R; Brychta T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
[TBL] [Abstract][Full Text] [Related]
4. [Research progress on active ingredients of traditional Chinese medicines improved insulin resistance based on PPARs targets].
Jiang HJ; Zhang XJ; Zhang H; Yan JZ
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(22):4355-8. PubMed ID: 27097406
[TBL] [Abstract][Full Text] [Related]
5. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
Alemán G; Torres N; Tovar AR
Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity].
Fritsche A; Madaus A; Tschritter O; Ozeker M; Wulle EL; Machicao F; Häring H; Stumvoll M
Dtsch Med Wochenschr; 2001 May; 126(20):580-4. PubMed ID: 11402923
[TBL] [Abstract][Full Text] [Related]
8. [PPAR and diabetes].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors.
Nishii N; Takasu M; Soe OK; Maeda S; Ohba Y; Inoue-Murayama M; Kitagawa H
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):690-7. PubMed ID: 17512769
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
11. Catalase polymorphisms and metabolic diseases.
Hebert-Schuster M; Fabre EE; Nivet-Antoine V
Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):397-402. PubMed ID: 22617568
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
13. PPARs and the placenta.
Fournier T; Tsatsaris V; Handschuh K; Evain-Brion D
Placenta; 2007; 28(2-3):65-76. PubMed ID: 16834993
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
Lee BC; Lee HJ; Chung JH
Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
[TBL] [Abstract][Full Text] [Related]
15. Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.
Yong EL; Li J; Liu MH
Curr Opin Lipidol; 2008 Apr; 19(2):106-12. PubMed ID: 18388689
[TBL] [Abstract][Full Text] [Related]
16. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
18. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
19. PPARs: diverse regulators in energy metabolism and metabolic diseases.
Wang YX
Cell Res; 2010 Feb; 20(2):124-37. PubMed ID: 20101262
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.
Arck P; Toth B; Pestka A; Jeschke U
Biol Reprod; 2010 Aug; 83(2):168-76. PubMed ID: 20427759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
